Trial reportEuropean journal of pain (London, England)2026
Relationship Between Central Sensitization and Genetic Polymorphisms-A Case-Control Study in Fibromyalgia.
Trial report in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04624581 (Genetic Characteristics and Determinants of Central Sensitization of Nociception in Fibromylagic Syndrome), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Genetic Characteristics and Determinants of Central Sensitization of Nociception in Fibromylagic Syndrome
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFibromyalgia is a syndrome characterised by widespread chronic pain, which is believed to be mediated by a state of central sensitisation (CS). Based on the hypothesis that CS itself could have genetic determinants, our aim was to further explore this pathway.
methodsThis study included 201 women with fibromyalgia and 40 healthy women matched on age and menopausal status. The nociceptive flexion reflex (NFR) threshold was used as a surrogate marker of CS. Genotyping of 60 candidate-genes likely to influence the pathogenesis of fibromyalgia or chronic pain was explored in all subjects.
resultsThe NFR threshold was lower in patients (n = 141, median and [interquartile range]: 34 mA [24-46]) than in controls (n = 35, 58 mA [44-77], p = 0.0003), but none of the tested polymorphism genotype was significant. An association was found between fibromyalgia and three polymorphisms related to TNF, TACR1, and IL10 genes, either by testing the simple allelic frequency or an additive model. When the analysis was adjusted on NFR threshold, only the association with TACR1 was still significant, along with other associations with polymorphisms related to FAAH, HTR1A, and MYT1L. Associations were however non significant when a Bonferroni's correction was applied.
conclusionsThis study confirmed that CS is a major feature of fibromyalgia. Although several polymorphisms stand out in the analysis, no significant relationship between CS and 60 selected candidate-genes genotype could be highlighted. This information may help however to guide further research to explore this important pathway in larger well phenotyped cohorts. SIGNIFICANCE STATEMENT: Sixty selected fibromyalgia and pain candidate-genes have no significant association with the nociceptive flexion reflex, a surrogate marker of central sensitization in 201 fibromyalgia women. But the study may help however to guide further research to explore this important pathway in larger well phenotyped cohorts.
trial registrationClinicalTrials.gov identifier: NCT04624581.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.